EBSEROS Trademark

Trademark Overview

On Wednesday, April 22, 2020, a trademark application was filed for EBSEROS with the United States Patent and Trademark Office. The USPTO has given the EBSEROS trademark a serial number of 88882401. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 13, 2023. This trademark is owned by Supernus Pharmaceuticals, Inc.. The EBSEROS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
ebseros

General Information

Serial Number88882401
Word MarkEBSEROS
Filing DateWednesday, April 22, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 1, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSupernus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameSupernus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, November 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, April 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 20, 2023SOU EXTENSION 5 GRANTED
Thursday, April 13, 2023SOU EXTENSION 5 FILED
Thursday, April 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Saturday, October 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 13, 2022SOU EXTENSION 4 GRANTED
Thursday, October 13, 2022SOU EXTENSION 4 FILED
Thursday, October 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 31, 2022ASSIGNED TO EXAMINER
Friday, April 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 13, 2022SOU EXTENSION 3 GRANTED
Wednesday, April 13, 2022SOU EXTENSION 3 FILED
Wednesday, April 13, 2022SOU TEAS EXTENSION RECEIVED
Saturday, October 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 13, 2021SOU EXTENSION 2 GRANTED
Wednesday, October 13, 2021SOU EXTENSION 2 FILED
Wednesday, October 13, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 13, 2021SOU EXTENSION 1 GRANTED
Tuesday, April 13, 2021SOU EXTENSION 1 FILED
Tuesday, April 13, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 13, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 15, 2020ASSIGNED TO EXAMINER
Friday, May 1, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 25, 2020NEW APPLICATION ENTERED

Related Keywords

ebseros diseases system nervous disorders neurological peripheral psychiatric central therapeutic preparations